2017 Annual Conference Oral and Poster Presentations

2017 Annual Conference Oral and Poster Presentations

REGISTRY OF THE FUTURE

Session
Registry of the Future Opening Session; Dr. Chuck Wiggins, New Mexico Tumor Registry
PRISM A System for Categorizing Disease; Dr. Lynne Penberthy, National Cancer Institute
Reducing Respondent Burden through Record Linkage & Automation of the Duplicate Resolution Process; Patricia Murison, Statistics Canada
The Beau Biden Cancer Moonshot and the NCI Blue Ribbon Panel Recommendations; Dr. Lynne Penberthy, National Cancer Institute
Visualizing Big Cancer Data - A Future of Cancer Care; Andrew Stewart, American Society of Clinical Oncology

TUESDAY MAIN CONFERENCE

Section
 Session
Plenary Session #1: Breaking Barriers - International Cancer Surveillance
1PL1Registries in the Future of International Cancer Control; Dr. Heather Bryant, Canadian Partnership Against Cancer
1PL2Cancer Surveillance in Mexico; Dr. Alejandro Mohar, National Cancer Research Institute of Mexico
1PL3NCI Center for Global Health: Global Cancer Surveillance and Cancer Control; Dr. Lisa Stevens, National Cancer Institute, Center for
Global Health
2017 Presentation of the Calum S. Muir Memorial Award and Constance L. Percy Award for Distinguished Service
NAACCR YOUNG Talk: Essential TNM; Kevin Ward, PhD
Concurrent Session #1
Concurrent 1-AExpanding the Role of Cancer Registries
1A14708The Changing Role of the Cancer Registry: "Beyond Tumour Registration"; L Bowers, Data Quality Management Committee, ON, Canada
1A24831Survivorship Care Planning and Cancer Registries: Can we Help Each Other While Also Helping Patients?; C Bledsoe, DB Consulting Group, Silver Spring, MD, United States
1A34698An Approach to Strengthen Cancer Prevention and Control in the English- and Dutch-Speaking Caribbean; S Quesnel-Crooks, Caribbean Public Health Agency (CARPHA), Port of Spain, Trinidad and Tobago
1A44712Fundamental Learning Collaborative for the Cancer Surveillance Community (FLccSC); G. Levin, Florida Cancer Data System, Miami, FL, United States; S. Bolick, South Carolina Central Cancer Registry, Columbia, SC, United States
Concurrent 1-BRegistry Data Tools
1B14695SEER Implementation of the Multiple Primary and Histology Coding Rules; F. Depry, Information Management Services, Inc., Calverton, MD, United States
1B24792I See it Now! New Data Visualizations of U.S. Cancer Statistics; L. Pollack, CDC, Division of Cancer Prevention and Control, Atlanta, GA, United States
1B34819Transitioning Forward with EDITS50 Tools: Editwriter V5 and GenEDITS Plus V5; M. Esterly, Northrop Grumman, Atlanta, GA, United States
1B44825Advancing the Infrastructure for Cancer Surveillance: Enhancing SEER*DMS Through a Multi-Tiered Usability Assessment Approach; M. Matatova, National Cancer Institute, Rockville, MD, United States
Concurrent 1-CImproving Cancer Treatment Linkage
1C14826The Canadian Cancer Treatment Linkage Project; P. Murison, Statistics Canada, Ottawa, ON, Canada
1C24714Finding Treatment Data in All the Right Places! Linking Hospital Electronic Medical Records & Prescription Dispensing Data to the Central Registry; K. Vriends, Prince Edward Island Cancer Registry, Charlottetown, PE, Canada
1C34878Developing an Oncology Treatment Resource for Claims-Based Research: Innovation with Medications; D. Rivera, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, United States
1C44621Linkage of Indiana State Cancer Registry and Indiana Network for Patient Care Data; L. Ruppert, Indiana State Department of Health, Indianapolis, IN, United States
Concurrent 1-DComposite Cancer Burden Indices
1D14728Guide to Developing Composite Cancer Indices for Your Registry; E. Feuer, National Cancer Institute, Bethesda, MD, United States
1D24726Using a Simple Rank Sum Technique to Create an Index of the Cancer Burden; T. Tucker, Kentucky Cancer Registry, Lexington, KY, United States
1D34727Point and Intervals Estimates for Composite Cancer Burden Indices for Small Geographic Units; B. Huang, Kentucky Cancer Registry, Lexington, KY, United States
1D44725Confidence Intervals for Ranking Health Indices Across Geographic Units; L. Zhu, National Cancer Institute, Bethesda, MD, United States
Concurrent 1-ESurvival Analysis
1E14671Assessment of Lead-Time Bias in Estimates of Relative Survival for Breast Cancer; T.M-L. Andersson, Karolinska Institutet, Stockholm, Sweden
1E24767Using Loss in Expectation of Life to Further Quantify Population Differences in Cancer Survival; M. Rutherford, University of Leicester, Leicester, Great Britain
1E34847The Impact of Including Higher Order Primaries in Survival Analyses: Ontario, Canada; D. Nishri, Cancer Care Ontario, Toronto, ON, Canada
1E44780Impact and Implications of Cancer Death Status Reporting Delay on Relative Survival Analysis with Presumed-Alive Assumption; X. Dong, ICF Inc., Fairfax, VA, United States
Concurrent 1-FStudent Presentations I
1F1S4946Thyroid Cancer in New Mexico: Time Trends and Surgical Treatment Preferences, 1981-2013; I. Mahdi, New Mexico Tumor Registry, Albuquerque, NM, United States
1F2S4947Analysis of Breast Cancer Treatment Delays in New Jersey Patients; K. DeMair, Rutgers School of Public Health, New Jersey State Cancer Registry, New Brunswick, NJ, United States
1F3S4764Initial Systemic Treatment in Stage IV Non-Small Cell Lung Cancer (NSCLC), California, 2012-2014; F. Maguire, Institute for Population Health Improvement, University of California Davis Health System, Sacramento, CA, United States
1F4S4744Excess Treatment-Related Incidence of Diseases of the Circulatory System in Patients Diagnosed with Hodgkin Lymphoma; C.E. Weibull, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
1F5S4853Descriptive Analysis of Breast Cancer Surgery Trends in South Carolina, 2005-2013; J. Clerville, South Carolina Central Cancer Registry, Columbia, SC, United States
Concurrent Session #2
Concurrent 2-ARegistry of the Future
2A14658We Need to Talk About Recurrence: How Can We Identify Patients With Progressive Cancers When We Cannot Even Agree on Definitions?; L. Elliss-Brookes, London, England, United Kingdom
2A24807Opportunities for Connected Health Research and Interventions through NCI SEER and the FCC Broadband Mapping Tool; Y. Shaikh, Federal Communications Commission, Rockville, MD, United States
2A34788Towards an Integration of the Genome and Exposome with Cancer Registry Data; G. Jacquez, BioMedware, Ann Arbor, MI, United States
2A44842Updating Volume V for the Registry of the Future; NAACCR Volume V Revision Task Force, NAACCR, Springfield, IL, United States
Concurrent 2-BCancer in Native Peoples
2B14700Improving American Indian and Alaska Native Cancer and Mortality Surveillance Data; M.A. Jim, Centers for Disease Control and Prevention, Albuquerque, NM, United States
2B24799Potentially Preventable Cancers Among Alaska Native People; S. Nash, Alaska Native Tribal Health Consortium, Anchorage AK, United States
2B34710A Cancer Profile for First Nations in Ontario Achieved Through Linked Registry Data and Partnerships; S. Jamal, Cancer Care Ontario, Toronto, ON, Canada
2B49999Choice of Relative or Cause-Specific Approach to Cancer Survival Analysis Impacts Estimates Differentially by Cancer Type, Population and Application: Evidence From a Comparison of First Nations and Non-Aboriginals in Canada; D. Withrow, University of Toronto, Toronto, ON, Canada
Concurrent 2-CMixed Bag
2C14676Physician Medical Claims Reporting in Florida; M.N. Hernandez, Florida Cancer Data System, University of Miami, Miami, FL,
United States
2C24858Occupational Cancer Surveillance in the Age of Restricted Identifier Access: A Linkage of Florida Cancer Data System (FCDS) Data with Firefighter Certification Records; D.J. Lee, University of Miami, Miami, FL, United States
2C34711Progress Update on Electronic Cancer Reporting Through Meaningful Use at the North Carolina Central Cancer Registry; C. Rao, North Carolina Central Cancer Registry, Raleigh, NC, United States
2C44872How Stage Data Collected From Cancer Centres is Used by the Ontario Cancer Registry (OCR), Compared to Cancer Care Ontario’s (CCO) Corporate and Cultural Assumptions of its Value, an Environmental Scan; M.J. King, Ontario Cancer Registry, Toronto, ON, Canada
Concurrent 2-DEpidemiology I
2D14839Latest Trends in Thyroid Cancer Incidence in Females by Race/Ethnicity in the United States and Los Angeles County; A. Sipin, Los Angeles Cancer Surveillance Program, University of Southern California, Los Angeles, CA, United States
2D24699Trends in Incidence, Mortality, and Survival for Kidney Cancer in Ontario, 1981–2012; A. Anam, Cancer Care Ontario, Toronto, ON, Canada
2D34874Stomach Cancer Trends and Potential Relationship to H. Pylori; M. Whiteside, Tennessee Department of Health, Nashville, TN, United States
2D44706Inferring Prostate Cancer Natural History in African Americans Using Cancer Surveillance Models; R. Etzioni, Fred Hutchinson Cancer Research Center, Seattle, WA, United States
Concurrent 2-ESurvival Differences
2E14811Global Surveillance of Cancer Survival (CONCORD-3); C. Allemani, London School of Hygiene and Tropical Medicine, London, United Kingdom
2E24781Population-Based Cancer Survival in Canada and the United States: Comparison by Socio-Economic Position; H. Weir, Centers for Disease Control and Prevention, Atlanta, GA, United States
2E34776International Cancer Survival Differences and Cancer Registration Practice in ICBP Jurisdictions - Quantitative Analysis; M. Eden, Public Health England, National Cancer Registration & Analysis Service, Cambridge, Great Britain
2E44789Geographic Variation in Cervical Cancer Survival by Age and Morphology (CONCORD-2); R. Harewood, Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom
Concurrent 2-FStudent Presentations II
2F1S4795Developing a RESTful HTTP Service as a Frontend for the CDC TNM Staging API; R. Chui, Kentucky Cancer Registry, Lexington, KY, United States
2F2S4828Accuracy of the HPV Status Site Specific Factor 10 (SSF-10) Variable for Head and Neck Cancer (HNC) Cases in Iowa: 2010-2014; A. Kahl, University of Iowa College of Public Health & the Iowa Cancer Registry, Iowa City, IA, United States
2F3S4943Cancer Incidence and Trends in Rural and Urban Populations in the United States; W. Zahnd, University of Illinois Urbana-Champaign, Southern Illinois University School of Medicine, Springfield, IL, United States
2F4S4945Cervical Cancer Survival Among Young California Women; A.K. Klapheke, University of California, PHI/Cancer Registry of Greater California, Sacramento, CA, United States
NAACCR YOUNG Talk: Characterization of Sexual Gender Minority Cancer Cases; Frank Boscoe, PhD, Scarlett Gomez, PhD
Plenary Session #2: Cancer Surveillance In Action: An International View
2PL1International Collaborations in Cancer Research; Dr. Michel Coleman - CONCORD, London School of Hygiene and Tropical Medicine
2PL2Working Internationally with Population-Based Registries; Dr. Marianne Berwick, University of New Mexico
2PL3NCI Center for Global Health: Global Cancer Surveillance and Cancer Control; Lisa M. Stevens
Deputy Director, Center for Global Health
NAACCR Lightning Round - Late Breaker Topics and Up To Date Announcements
Birds of a Feather Open Discussion Forum “Attrition in our Workplace-Affect, Attitude & Acceptance”

WEDNESDAY MAIN CONFERENCE

Section
 Session
Rise and Shine Session - Speaking up! Advocacy for Cancer Surveillance
Plenary Session #3: Cancer Surveillance in American Indians/Alaska Natives/Canadian First Nations
3PL1Incidence of Primary Liver Cancer in American Indians and Alaska Natives, US, 1999-2009; Dr. Stephanie Melkonian, Centers for Disease Control and Prevention
3PL2Cancer Survival Among Alaska Native People; Dr. Sara Nash, Alaska Native Tumor Registry
3PL3An Introduction to a Tribally Operated Population-Based Cancer Registry; Sohail Khan, Cherokee Nation Cancer Registry
3PL4Cancer Surveillance Among Indigenous Populations in Canada; Dr. Diana Withrow, National Cancer Institute
NAACCR YOUNG Talk: WHO Classification of Central Nervous System Tumors - An Opportunity for Cooperation and Collaboration across Disciplines; Carol Kruchko
Concurrent Session #3
Concurrent 3-ACancer Reporting Strategies and Implications
3A14669Mining the Diagnostic Index to Improve Cancer Incidence Reporting; F.D. Vigneau, Wayne State University, Detroit, MI, United States
3A24659Emergency Diagnosis of Cancer and Previous Primary Care Consultations: Insights from Linked Cancer Patient Survey and Administrative Datasets; L. Elliss-Brookes, National Cancer Registration and Analysis Service, Public Health England, London, Great Britain
3A34801Comparability of Early Case Capture Pediatric and Young Adult Incidence Rates; R. Wilson, CDC, Atlanta, GA, United States
3A44803Evaluating Usefulness of Case Completeness Estimates as a Criterion for Inclusion in USCS; R. Wilson, CDC, Atlanta, GA, United States
3A54705Examination of Preliminary Cancer Surveillance Data From the National Program of Cancer Registries, Diagnosis Year 2012; M. Freeman, CDC, Atlanta, GA, United States
Concurrent 3-BTools and Analysis
3B14829An Integrated U.S. National Mortality Database by Nativity: Promises and Issues; M. Yu, National Cancer Institute, Bethesda, ML, United States
3B24871Comparison of Comorbidity Indices Derived from Claims Data; B. Huang, University of Kentucky, Lexington, KY, United States
3B34820Validation of an Alternative Approach to Ascertaining Vital Status Information on the Canadian Cancer Registry; L.F. Ellison, Statistics Canada, Ottawa, ON, Canada
3B44844Hysterectomy-Corrected Rates of Endometrial Cancer Among Women of Reproductive Age in the United States, SEER 1992-2010; A-M Noone, National Cancer Institute, Bethesda, MD, United States
Concurrent 3-CEpidemiologic Studies
3C14467Twelve-Year Study Update for a Postmarketing Case Series Study of Adult Osteosarcoma and Teriparatide in the U.S.; D. Harris, RTI Health Solutions, Research Triangle Park, NC, United States
3C24758Making an IMPACT: Optimizing Patient Recruitment in Hard to Reach Populations with NJSCR; N. Herman, New Jersey State Cancer Registry, Trenton, NJ, United States
3C34665An Ecological Study of Cancer and Fluoride in Drinking Water; L. Hounsome, Public Health England, London, Great Britain
3C44860Cancers Attributable to Excess Body Weight in Canada in 2010; A. Shaw, Public Health Agency of Canada, Ottawa, ON, Canada
3C54739Screening Recommendation and Breast Cancer Incidence in South Carolina: A BRFSS and Cancer Registry Analysis; D. Hurley, South Carolina Department of Health and Environmental Control, Columbia, SC, United States
Concurrent 3-DData Transmission Standards and "Fake Data"
3D14806Results of a Pilot Project Implementing the NAACCR XML Transmission Standard; I. Hands, Kentucky Cancer Registry and University of Kentucky Markey Cancer Center, Lexington, KY, United States
3D24855Breaking the Barrier of the NAACCR Data Transmission Layout with College of American Pathologists (CAP) Biomarker Templates; J. Seiffert, Northrop Grumman, under contract to CDC, Atlanta, GA, United States
3D34775Faking it: Building a Simulacrum of Non-Identifiable Modelled Cancer Data to Support Research; M. Eden, Public Health England, National Cancer Registration & Analysis Service, Cambridge, Great Britain
Concurrent 3-EImproving Cancer Treatment Data
3E14843Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation; E .Durbin, Kentucky Cancer Registry, Markey Cancer Center, University of Kentucky, Lexington, KY, United States
3E24817Better Late Than Never? Utah Cancer Registry’s Evaluation of 15-Month Re-Submission of Abstracts for Complete Treatment Data; S. McFadden, Utah Cancer Registry, Salt Lake City, UT, United States
3E34701Using Population-Based Cancer Registry Data to Extend Clinical Trial Findings: Saving More Lives; J.W. Morgan, Desert Sierra Cancer Surveillance Program, Loma Linda, CA , United States
3E44876Linkage Between Utah All-Payer Claims Database and Central Cancer Registry for Treatment and Tumor Marker Data; C. Sweeney, Utah Cancer Registry, Salt Lake City, UT, United States
3E54880Surveillance for BRCA and Lynch Syndrome Testing for Cancer Cases: Registry Ability to Obtain Risk Criteria and Genetic Counseling and Testing Data; C. Sweeney, Utah Cancer Registry, Salt Lake City, UT, United States
Concurrent 3-FStudent Presentations III
3F1S4691Measuring Net Cancer-Specific Survival in Brain and Other CNS Tumors: Cause-Specific Survival vs. Relative Survival; Q. Ostrom, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, United States, Central Brain Tumor Registry of the United States, Hinsdale, IL, United States
3F2S4703Stratifying Expected Mortality Rates Using Information from a Control Group: An Example Using Socioeconomic Status; H. Bower, Karolinska Institutet, Stockholm, Sweden
3F3S4849Lung Cancer Incidence, Tobacco Smoking and Environmental Pollutants: Application of Bayesian Hierarchical Models Using a Joint Modeling Approach; T.A. Norwood, Cancer Care Ontario, Toronto, ON, Canada, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
3F4S4704Pregnancy and Relapse Among Female Hodgkin Lymphoma Patients; C.E. Weibull, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

THURSDAY MAIN CONFERENCE

Section
 Session
Plenary Session #4: Registry of the Future Part I: Surveillance in an Era of Emerging Technology and Precision Medicine
4PL1Advances in Integrating Health Claims Data Into Cancer Registry Data Systems; Kevin Ward, PhD, Georgia Center for Cancer Statistics, Emory University; Gary Levin, BA, CTR, Florida Cancer Data System; Linda Coyle, Information Management Services, Inc.
4PL2Surveillance in an Era of Emerging Technology and Precision Medicine; Dr. Tanmoy Bhattacharya, Los Alamos National Laboratory
4PL3Building a Case for the Collection of Genomic Data in Cancer Surveillance; Dr. Allison Kurian, Stanford University
NAACCR YOUNG Talk: An Online Interactive Tool to Improve the Understanding of Cancer Survival Statistics; Paul Lambert, PhD
Concurrent Session #4
Concurrent 4-AData Quality Improvement
4A14805An Innovative Approach to Developing the SEER-Wide Quality Audit Plan; S. Cheng, Dilts+Partners, Plano, TX, United States
4A24870Breaking Barriers in Data Quality Assurance and Operational Process Improvements; W. Roshala, PHI/Cancer Registry of Greater California, Sacramento, CA, United States
4A34846Quality of Electronic Pathology (e-path) Records: a Function of Time, “X-Factors,” and One “Constant”; J. Harrison, New York State Cancer Registry, Albany, NY, United States
4A44879Automate and Standardize Follow-Back Using Rapid Software Development Platforms With Interactive Activity Management in a Short Timeframe; H. Kundeti, Cancer Registry of Greater California, Sacramento, CA, United States
Concurrent 4-BNatural Language Processing
4B14862The Development of the Clinical Document Annotation and Processing Pipeline to Facilitate the Integration of Natural Language Processing Within Cancer Surveillance; J. Boten, National Cancer Institute, Rockville, MD, United States
4B24835Creating an NLP Service to Codify Histopathology Reports at the California Cancer Registry; J. Patrick, HLA-Global, Sydney, NSW, Australia
4B34840Rebooting Cancer Data Through Structured Data Capture; G. Lee, Cancer Care Ontario, ON, Canada
4B44845Development of A Natural Language Processing (NLP) Workbench Web Services to Map Unstructured Clinical Information to Standardized Coded Data; S. Jones, CDC, Atlanta, GA, United States
Concurrent 4-CVirtual Pooled Registry Cancer Linkage System
4C14757Virtual Pooled Registry Update: Breaking Down Barriers to Multi-Registry Research Linkages and Building Capacity for Future Initiatives; C. Clerkin, NAACCR, Springfield, IL, United States
4C24824Breaking Barriers for Central Cancer Registry-Based Research: The New NIH Policy on Use of a Single Institutional Review Board for Multi-Site Research; D. Deapen, Los Angeles Cancer Surveillance Program, Los Angeles, CA, United States
4C34769Using the Virtual Pooled Registry – Cancer Linkage System for Interstate Deduplication; C. Johnson, Cancer Data Registry of Idaho, Boise, ID, United States
4C44893Virtual Pooled Registry Cancer Linkage System; A. Lake, Information Management Services, Inc., Rockville, MD, United States
Concurrent 4-DGIS Mapping Tools
4D14720Visual Display and Analysis of Geo-Referenced Cancer Data Made Easy With New R packages – Applications; L. Pickle, StatNet Consulting LLC, Gaithersburg, MD, United States
4D24734An Introduction to Using R for Mapping Tools; L. Zhu, National Cancer Institute, Rockville, MD, United States
4D34721Mapping Tools for the Visual Display and Analysis of Geo-Referenced Cancer Data and Examples; J. Pearson, StatNet Consulting LLC, Gaithersburg, MD, United States
4D44809Standardizing Address Cleaning for GIS Mapping; C. Lefante, Louisiana Tumor Registry, New Orleans, LA, United States
Concurrent 4-ECancer Disparities - SES
4E14709The Influence of Nativity, Neighborhood Socioeconomic Status, and Ethnic Enclave on Mortality Among Hispanic and Asian American/Pacific Islander Women Diagnosed with Endometrial Cancer in California During 1988–2011; S. Gomez, Cancer Prevention Institute of California, Fremont, CA, United States
4E24713How Much of the Racial/Ethnic Disparities in Cancer Survival in California is Explained by Differences in Tumor, Sociodemographic, Institutional and Neighborhood Characteristics? A Mediation Analysis; S. Gomez, Cancer Prevention Institute of California, Fremont, CA, United States
4E34823Treatment Disparities for Patients Diagnosed with Metastatic Bladder Cancer in California: Contribution of Socioeconomic Factors and Marital Status; R.D. Cress, Public Health Institute/CRGC, Sacramento, CA, United States
4E44732Addressing Racial Disparities in Breast Cancer Treatment Delays: An Application of Group Model Building; F. Williams, East Tennessee State University, Johnson City, TN, United States
4E54869Patient and Hospital Characteristics Associated with Nephron-Sparing Surgery for Small, Localized Kidney Cancers in California, 2012-2015; B.M. Giddings, California Cancer Reporting & Epidemiologic Surveillance Program, UC Davis Health System, Sacramento, CA, United States
Concurrent 4-FNew Data Uses
4F14787Data Visualization Assessment of the National Program of Cancer Registries (NPCR) Program Evaluation Instrument (PEI); S. Van Heest, Centers For Disease Control and Prevention, Atlanta, GA, United States
4F24778Case Investigation of Cervical Cancer (CICC) Study in 3 U.S Cancer Registries; V.B. Benard, Centers for Disease Control and Prevention, Atlanta, GA, United States
4F34841Meaningful Use Physician Reporting: Successes and Lessons Learned; W. Blumenthal, Centers For Disease Control and Prevention, Atlanta, GA, United States
4F44741Using the National Program of Cancer Registries to Monitor Tobacco Use; L. Pollack, CDC, Division of Cancer Prevention and Control, Atlanta, GA, United States
Concurrent Session #5
Concurrent 5-AColorectal Cancer
5A14812KRAS Testing, Tumor Location and Survival in Stage IV Colorectal Cancer Patients: SEER, 2010-2013; M. Charlton, University of Iowa College of Public Health & the Iowa Cancer Registry, Iowa City, IA, United States
5A24751Impact of Area-Poverty Rate on Late-Stage Colorectal Cancer Incidence in Indiana, 2010-2014; A. Raftery, Indiana State Department of Health, Indianapolis, IN, United States
5A34746Disparate Burden of Colorectal Cancer in New Jersey Women by Region and Age Group; A.B. Crosbie, NJ Department of Health, Cancer Epidemiology Services / New Jersey State Cancer Registry, Trenton, NJ, United States
Concurrent 5-BNatural Language Processing and Biomarker Linkage
5B14861De-Identification of Unstructured Clinical Text Documents; V. Petkov, NCI, Rockville, MD, United States
5B24864Identify Cancer Misdiagnoses Faster by Utilizing IBM Watson Explorer, a Natural Language Processing Tool; H. Kundeti, Cancer Registry of Greater California, Sacramento, CA, United States
5B34848Automated Coding of Key Case Identifiers from Text-Based Electronic Pathology Reports; G. Cernile, Artificial Intelligence In Medicine, Inc., Toronto, ON, Canada
5B44765Linkage of Cancer Registry Data to Tissue Specimens to Study Tumor Pathology and BRCA1 Mutation Status; A.S. Hamilton, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States
5B54786The Georgia California Genelink Study Initiative: Strategy, Methods and Outcomes; S. Katz, University of Michigan, Ann Arbor, MI, United States
Concurrent 5-CLinkage Methods and Issues
5C14827Precision Cancer Surveillance: What Can We Learn from Novel Data Linkages with SEER?; D. Rivera, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, United States
5C24761Getting the Data is Only Half the Battle: Obstacles to Data Sharing with Linked Registry Data; E. Miller, National Cancer Institute, Rockville, MD, United States
5C34694Probabilistic Record Linkage at the Florida Cancer Data System: A Data Science Project Using R and Stata; A. Alexandersson, Florida Cancer Data System, Miami, FL, United States
5C44768The Disease Index Comparison Supercharged: More Complex Matching and Linkages; W. Ross, Westat, Inc., Rockville, MD, United States
Concurrent 5-DSmall Area Analysis
5D14731A Standard Procedure for Using Cancer Registry Data to Investigate Cancer Clusters; L. Hounsome, Public Health England, Bristol, England, United Kingdom
5D24772Investigating a Prostate Cancer “Epidemic”; M.J. Schymura, New York State Cancer Registry, Albany, NY, United States
5D34692Characteristics of Philadelphia Census Tracts with High Prostate Cancer Risk; C. Zeigler-Johnson, Thomas Jefferson University, Philadelphia, PA, United States
5D44815An Approach Using Cancer Registry Data to Address Cancer Burden in an NCI Cancer Center Catchment Area; M. McKinley, Fremont, CA, United States
Concurrent 5-EBreast Cancer
5E14790Risk of Second Cancer After Breast Cancer Treatment; H. Jiang, Cancer Care Ontario, ON, Canada
5E24784Breast Cancer Biomarker Data Quality Evaluation Among Central Cancer Registries in the U.S.: 2010-2013; M. Wu, Centers for Disease Control and Prevention, Atlanta, GA, United States
5E34875Patterns and Recent Trends in Mastectomy and Breast Conserving Surgery for Women with Early-Stage Breast Tumors in Missouri; C.L. Schmaltz, Missouri Cancer Registry and Research Center, Columbia, MO, United States
5E44785Patterns and Factors Associated with Initial Treatment of Ductal Carcinoma in Situ Breast Cancer in the U.S.; M. Wu, Centers for Disease Control and Prevention, Atlanta, GA, United States
Plenary Session #5: Registry of the Future Part II: Visioning a Powerful Cancer Surveillance System for North America
5PL1What ICD-11 Might Mean for Cancer Registries and Cancer Surveillance; Dr. Robert Anderson, Centers for Disease Control and Prevention, NCHS
5PL2CDC’s Vision for the Future of Cancer Surveillance; Dr. Lisa Richardson, Centers for Disease Control and Prevention
5PL3The Evolution of SEER – Envisioning the Future; Dr. Lynne Penberthy, National Cancer Institute
5PL4Recap of Registry of the Future Workshop and Next Steps for the NAACCR Community; Dr. Antoinette Stroup, New Jersey State Cancer Registry, NAACCR President-Elect

POSTER ABSTRACT PRESENTATIONS

Abstract Number
Title
Presenter
  
Country
Preliminary Category
4666Using Natural Language Processing to Screen and Classify Pathology ReportsCheryl MoodySacramentoCAUnited StatesOperations
4667Cancer Case Transmission to Central Cancer Registry using Web Services (C/NExT and Eureka)Timothy DavisonSacramentoCAUnited StatesOperations
4672TNM Edits are Staging GuardrailsD GressChicagoILUnited StatesOperations
4690Utilizing Hospital Cancer Registry Operations to Implement Statewide Early Case Capture for all CancersD RousseauProvidenceRIUnited StatesOperations
4697Finding "Zombies" in Your Database by Confirming Vital StatusDK O'BrienAnchorageAKUnited StatesOperations
4716Oklahoma Central Cancer Registry Audit Process for Evaluating Data Quality and CompletenessSusan NagelhoutOklahoma CityOKUnited StatesOperations
4723How important is non-hospital cancer case reporting to the New York State Cancer Registry's ability to describe the cancer burden? Let us count the ways.AR KahnAlbanyNYUnited StatesOperations
4735Minimizing the Impacts of Address-County Uncertainty to North Carolina Cancer StatisticsC KlausRaleighNCUnited StatesOperations
4736Calibrating the NAACCR Hispanic Identification Algorithm (NHIA)X ZhangAlbanyNYUnited StatesOperations
4745The Case Investigation of Cervical Cancer (CICC) Study: Chart Abstraction from Primary and Specialty Care Providers 5 Years Prior to Patient DiagnosisA GreekAtlantaGAUnited StatesOperations
4748Meaningful Use Cancer Reporting: How Meaningful is it? An Analysis of Data Submitted to the Maryland Cancer RegistryD NgRockvilleMDUnited StatesOperations
4753Addressing Reporting Gaps in MarylandM MesnardRockvilleMDUnited StatesOperations
4754Coding Software for Cancer Registry Industry and Occupation: National Institute for Occupational Safety and Health Industry and Occupation Computerized Coding System (NIOCCS)S NowlinCincinnatiOHUnited StatesOperations
4756Presence of Codable Industry and Occupation in California Cancer Registry Data: Differences by Patient Demographics, Payor, Casefinding Source, and Type of MalignancySR SilverCincinnatiOHUnited StatesOperations
4759Improving the Accuracy of Type of Reporting Source Data Field at the New Jersey State Cancer RegistrySuzanne SchwartzTrentonNJUnited StatesOperations
4771Exploring a new dataset: Primary care prescriptions pre- and post-cancer diagnosis in EnglandL Elliss-BrookesLondonEnglandUnited KingdomOperations
4774United Kingdom and Ireland Association of Cancer registries (UKIACR) Performance Indicators 2017 ReportCeri WhiteCardiffWalesUnited KingdomOperations
4793Meaningful Use Registration and Reporting in TennesseeJ RichardsNashvilleTNUnited StatesOperations
4798Childhood Cancer Data Collection: A Trend Analysis of Completeness and Data Quality from NPCR-ECC (October 2012- October 2016 Submissions)Kevin ZhangRockvilleMDUnited StatesOperations
4813Data Quality Assessment of Melanoma Tumor Depth Measurement in SEERC LamRockvilleMDUnited StatesOperations
4814Death Clearance: Changing Follow-back Focus from Physician to HAN FacilityK HarringtonRaleighNCUnited StatesOperations
4822Improving Completeness of Treatment Documentation Through 15-Month Resubmission of Data in New JerseySM HillTrentonNJUnited StatesOperations
4830Defining Risk Factor-Associated Cancers in Cancer Registry DataS Jane HenleyAtlantaGAUnited StatesOperations
4832Assessing the Accuracy of Registry-Based Tobacco Use Status and Utility for Patient Recruitment into Tobacco TrialsS. Jane HenleyAtlantaGAUnited StatesOperations
4837Resubmission of Data from Hospitals to Improve Completeness of Treatment data: A Pilot StudyC PhillipsHartfordCTUnited StatesOperations
4850Use of Georgia Cancer Registry Data for Cancer Planning: Georgia's ApproachI. WalkerAtlantaGAUnited StatesOperations
4856Recovering treatment in Puerto Rico: An agreement evaluation using administrative claims dataY Román-RuizBarcelonetaPuerto RicoOperations
4857Automated Tumor Linkage and the Future of Quality ControlS WoodSacramentoCAUnited StatesOperations
4865The Completion of Chronic Comorbidity Reporting from Hospital Inpatient Discharge Data Varies by Observed Time WindowsYong YiNew OrleansLAUnited StatesOperations
4866Leveraging business intelligence tools in support of cancer case acquisition and auto versus manual processing of dataG CiorniiSacramentoCAUnited StatesOperations
4867Biorepositories and Cancer Registries the Perfect MatchI ZacharyColumbiaMOUnited StatesOperations
4868Endless opportunities: International and national collaborations to address and solve cancer registry challengesJ Jackson-ThompsonColumbiaMOUnited StatesOperations
4873Evolution of the Metro Chicago Breast Cancer Registry (MCBCR)TA DolecekChicagoILUnited StatesOperations
Abstract Number
Title
Presenter
Country
Preliminary Category
4441Trends in colorectal cancer survival in Arab World, 1990-2009Zoubida ZaidiSetifAlgeriaResearch
4442The descriptive epidemiology of gynecologic cancers: An international comparison of incidence, survival and mortalityZoubida ZaidiSetifAlgeriaResearch
4657Assessing the effectiveness of the England-wide Be Clear on Cancer campaignsL Elliss-BrookesLondonEnglandUnited KingdomResearch
4663Frequency of synchronous brain metastases at time of primary cancer diagnosis in the US, 2010-2013Q OstromClevelandOHUnited StatesResearch
4664Cancer and Heart Disease Age-Adjusted Mortality Trends in California from 1970 to 2014J.A. KillionSacramentoCAUnited StatesResearch
4696Obesity and the Impact on Endometrial Cancer in OklahomaR EspinozaOklahoma cityOKUnited StatesResearch
4707Cancer Prevalence in California on January 1, 2013Y ChenSacramentoCAUnited StatesResearch
4715Trends in Cancer Survival in California by Health Insurance Status: 1997 to 2013S. GomezFremontCAUnited StatesResearch
4718The impact of obesity on depression among adult cancer survivors residing in BrazilS.C. OanceaGrand ForksNDUnited StatesResearch
4729Stage-specific cancer survival in EnglandM EdenBristolEnglandUnited KingdomResearch
473030-day mortality following systemic anti-cancer therapy for breast and lung cancer: which factors increase the risk?Luke HounsomeBristolEnglandUnited KingdomResearch
4733Colorectal Cancer Incidence Trends in Massachusetts by Tumor Location, 1995-2014A MacMillanBostonMAUnited StatesResearch
4740A County Level Ecological Examination of Cancer Screenings, Early Stage Incidence and Mortality in the State of MissouriY YoshidaColumbiaMOUnited StatesResearch
4743Increased incidence trends of colorectal cancer among patients younger than 50 years by race/ethnicity, age and stage at diagnosis in California, 1990–2013Renata AbrahaoFremontCAUnited StatesResearch
4747The relationship of myelodysplastic syndrome (MDS) and chronic lymphocytic leukemia (CLL) to other hematopoietic cancers in Massachusetts, 1995-2014R KnowltonBostonMAUnited StatesResearch
4749Trends in Prostate Cancer Incidence in New Jersey Men by Race/Ethnicity, Age Group and Stage at Diagnosis after Changes in Prostate Specific Antigen Screening Recommendations, 1990-2014KS PawlishTrentonNJUnited StatesResearch
4750Colorectal Cancer Incidence Declining in New JerseyJ. LiTrentonNJUnited StatesResearch
4752Hot-Spotting Preventable Cancers: Done RightA Holt, R DelongchampLittle RockARUnited StatesResearch
4763Cancers with Increasing Trends Related to Obesity and Low Physical Activity in New Jersey: Variations by CountyA StroupTrentonNJUnited StatesResearch
4766Mapping Alaska Stomach Cancer Incidence Relative to the Geographic Distribution of Races in the Statewide PopulationDK O'BrienAnchorageAKUnited StatesResearch
4773Assessing Colonoscopy Prevalence in Arkansas Using Small Area MethodsM AstorConwayARUnited StatesResearch
4777Variation in Routes to Diagnosis by sex, age and deprivation across nine yearsL Elliss-BrookesBristolEnglandUnited KingdomResearch
4779Age-Period-Cohort analysis of Melanoma, Leukemia and Thyroid cancer in Ontario, CanadaYing WangTorontoONCanadaResearch
4783Racial and ethnic differences in breast cancer incidence in young women by age and breast cancer subtypeMeredith ShoemakerAtlantaGAUnited StatesResearch
4791Characterization of Second Primary Malignancies in OhioJ StephensColumbusOHUnited StatesResearch
4800Time between breast cancer diagnosis and treatment among Alaska Native peopleS NashAnchorageAKUnited StatesResearch
4816Recent Trends and Patterns in Diagnosis and Survival of Prostate Cancer by Race/Ethnicity in CaliforniaL LiuLos AngelesCAUnited StatesResearch
4818Association of the Puerto Rico Tobacco Control Policies and the Decreasing Trend in Lung and Bronchus Cancer MortalityM AlvaradoSan JuanPuerto RicoResearch
4821Worldwide Incidence of Hepatocellular Carcinoma: a 10-year ForecastEG RodriguesBurlingtonMAUnited StatesResearch
4833HPV-Associated Cancer Incidence, United States 2009-2013S. Jane HenleyAtlantaGAUnited StatesResearch
4838The burden of rare cancers in the United StatesC DeSantisAtlantaGAUnited StatesResearch
4851Utilization of Proton Beam Therapy: A Population-based Assessment of California, 1988-2014A Parikh-PatelSacramentoCAUnited StatesResearch
4854Personalized estimates of prostate cancer overdiagnosis: Model predictions using registry data on incidence rates and life expectancyR GulatiSeattleWAUnited StatesResearch
4863Validate the need for procuring potentially life saving statewide alert systems for various cancer misdiagnosesDanielle RodriguezSacramentoCAUnited StatesResearch
4877Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico Hispanic PopulationKJ ORTIZ-ORTIZSan JuanPuerto RicoResearch
4760Ovarian Cancer Prevalence Corrected for OophorectomyQ ChenLexingtonKYUnited StatesResearch
Abstract Number
Title
Presenter
Country
Preliminary Category
4762What are the Geographical Differences Among Children and Adolescents with Brain and Other CNS Tumors in California? Does Any Clustering Exist?Danielle RodriguezCAUnited StatesStudent
4859Racial/Ethnic Differences in Thyroid Cancer Incidence in the United States, 2007-2013Kristin WeeksIAUnited StatesStudent
4884The Impact of a Cancer Diagnosis on the Survival of HIV-Infected Individuals Living in South Carolina in the Post-ART Era.Ben HallowellGAUnited StatesStudent
4885The Impact of a Prior HIV/AIDS Diagnosis on the Survival of Cancer PatientsBenjamin HallowellGAUnited StatesStudent
4886Adherence and Perceived Barriers for Screening of Hepatocellular Carcinoma among High-risk Chinese PatientsK XuNEUnited StatesStudent
4924Nebraska Immigrant Populations and Cancer: A Comprehensive Analysis using Nebraska Cancer Registry DatabaseK XuNEUnited StatesStudent
4937Estimating the Impact of a Cancer Diagnosis on Life Expectancy by Socioeconomic Group for a Range of Cancer Types in EnglandElisavet SyriopoulouLeicesterGreat BritianStudent
4944Estimated Female Breast Cancer Mortality-to-Incidence Ratios (MIRs) on Senatorial Districts Grouped to County Boundaries in Missouri, 2008 - 2012AAB Ben RamadanMOUnited StatesStudent
4948Using Behavioral Risk Factor Surveillance System (BRFSS) Data to Estimate County-Level Colorectal Cancer Screening Prevalence in Missouri (MO)Jiang DuMOUnited StatesStudent
4949American Thyroid Association (ATA) guideline Adherence and Physician-Based Barriers and Facilitators of Initial Treatment for Differentiated Thyroid Cancer in Canada and the United States: A Systematic ReviewTA NorwoodONCanadaStudent

Copyright © 2016 NAACCR, Inc. All Rights Reserved | Terms of Use | naaccr-swoosh-only See NAACCR Partners and Sponsors